Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery discloses Wee1 inhibitors

May 18, 2020

TNFAIP2 identified as potential therapeutic target in platinum-resistant urothelial carcinoma

May 18, 2020

Designer proteins for RSV vaccine

May 18, 2020

Microbiome modulates effects of ALS mutation

May 18, 2020

Interim phase II data for apalutamide plus abiraterone acetate/prednisone in prostate cancer

May 18, 2020

First-in-human data for novel proliposomal paclitaxel, TSD-001, in NMIBC

May 18, 2020

Genenta presents phase I/II data for Temferon cell-based therapy in patients with GBM

May 18, 2020

Phase IIb study of PTI-125 in Alzheimer's disease does not meet primary endpoint

May 18, 2020

NantKwest and ImmunityBio to begin phase II study of combination immunotherapy

May 18, 2020

FDA clears IND for LB-1148 in COVID-19-associated pulmonary dysfunction

May 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...